0.7433
price down icon4.83%   -0.0377
pre-market  Pre-market:  .77   0.0267   +3.59%
loading
Biodesix Inc stock is traded at $0.7433, with a volume of 235.17K. It is down -4.83% in the last 24 hours and down -22.81% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.781
Open:
$0.77
24h Volume:
235.17K
Relative Volume:
0.68
Market Cap:
$108.51M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-1.1435
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-12.55%
1M Performance:
-22.81%
6M Performance:
-58.01%
1Y Performance:
-49.44%
1-Day Range:
Value
$0.7346
$0.7864
1-Week Range:
Value
$0.7346
$0.9033
52-Week Range:
Value
$0.7002
$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name
Name
Biodesix Inc
Name
Phone
303-417-0500
Name
Address
919 WEST DILLON ROAD, LOUISVILLE
Name
Employee
273
Name
Twitter
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
BDSX's Discussions on Twitter

Compare BDSX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
BDSX
Biodesix Inc
0.7433 108.51M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
508.90 191.99B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
204.09 145.87B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
117.33 33.47B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
406.29 33.04B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
181.43 31.99B 15.41B 1.37B 2.11B 7.50

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-16-24 Initiated Scotiabank Sector Outperform
Jul-26-24 Initiated Craig Hallum Buy
May-13-24 Initiated TD Cowen Buy
May-03-24 Initiated Lake Street Buy
Nov-17-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-23-20 Initiated BTIG Research Buy
Nov-23-20 Initiated Canaccord Genuity Buy
Nov-23-20 Initiated Morgan Stanley Overweight
Nov-23-20 Initiated William Blair Outperform
View All

Biodesix Inc Stock (BDSX) Latest News

pulisher
Mar 11, 2025

Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat

Mar 11, 2025
pulisher
Mar 08, 2025

Biodesix's (BDSX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

Biodesix (NASDAQ:BDSX) Issues Quarterly Earnings Results - MarketBeat

Mar 07, 2025
pulisher
Mar 07, 2025

Q1 Earnings Forecast for Biodesix Issued By William Blair - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

Biodesix improved sales, cut losses in fourth quarter, fiscal 2024 - BizWest

Mar 06, 2025
pulisher
Mar 06, 2025

Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News

Mar 04, 2025
pulisher
Mar 04, 2025

Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

12 Penny Stocks with Insider Buying in 2025 - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Mar 04, 2025
pulisher
Mar 03, 2025

Biodesix Reports Strong 2024 Financial Performance - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

BIODESIX Earnings Results: $BDSX Reports Quarterly Earnings - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings call transcript: Biodesix Q4 2024 beats revenue expectations - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Biodesix earnings beat by $0.01, revenue topped estimates - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Flash (BDSX) BIODESIX INC. Reports Q4 Revenue $20.4M, vs. FactSet Est of $19.9M - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire

Mar 03, 2025
pulisher
Mar 02, 2025

Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN

Mar 02, 2025
pulisher
Mar 01, 2025

Biodesix (BDSX) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead O - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Biodesix (BDSX) to Release Earnings on Monday - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Biodesix to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 26, 2025
pulisher
Feb 26, 2025

Biodesix Leadership to Share Company Vision at Major Healthcare ConferenceWhat Will They Reveal? - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

Financial Analysis: Biodesix (NASDAQ:BDSX) versus First Choice Healthcare Solutions (OTCMKTS:FCHS) - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

Insiders are the top stockholders in Biodesix, Inc. (NASDAQ:BDSX), and the recent 10% drop might have disappointed them - Simply Wall St

Feb 24, 2025
pulisher
Feb 18, 2025

Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq

Feb 18, 2025
pulisher
Feb 18, 2025

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire

Feb 18, 2025
pulisher
Feb 17, 2025

Insider Selling: Biodesix, Inc. (NASDAQ:BDSX) CEO Sells 83,660 Shares of Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) Insider Gary Anthony Pestano Sells 16,748 Shares - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) CFO Robin Harper Cowie Sells 24,664 Shares - MarketBeat

Feb 17, 2025

Biodesix Inc Stock (BDSX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$142.51
price down icon 1.38%
diagnostics_research DGX
$168.82
price up icon 1.44%
diagnostics_research LH
$235.65
price down icon 0.50%
diagnostics_research WAT
$364.44
price down icon 2.33%
diagnostics_research MTD
$1,201.99
price down icon 1.15%
diagnostics_research IQV
$181.43
price down icon 2.15%
Cap:     |  Volume (24h):